Division of Cardiology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.
Pacing Clin Electrophysiol. 2023 Dec;46(12):1643-1651. doi: 10.1111/pace.14862. Epub 2023 Oct 30.
Predictors of worsening atrioventricular valve regurgitation and left ventricular (LV) systolic function after implantation of a leadless pacemaker (LPM) remain unclear compared with those of a transvenous pacemaker (TPM).
We retrospectively analyzed 205 patients who were newly implanted with a permanent pacemaker (119 LPMs and 86 TPMs) and underwent transthoracic echocardiography before and 8 ± 5 months after implantation. We evaluated the worsening of tricuspid and mitral regurgitation (TR and MR), defined as at least one-grade aggravation in severity, and changes in LV ejection fraction (LVEF).
Worsening TR occurred more frequently in the LPM group compared to the TPM group (33% vs. 20%, p = .04); however, there was no significant difference between the two groups regarding worsening MR (26% vs. 18%, p = .18) and LVEF change (-2 ± 10% vs. -3 ± 8%, p = .40). In multivariable analysis, independent predictors for worsening TR, MR, and LVEF after implantation were found to be (1) the change from sinus rhythm at baseline to atrioventricular asynchronous right ventricular (RV) pacing (odds ratio [OR]: 5.68, 95% confidence interval [CI]: 1.94-16.70, p < .01); (2) the change from non-pacing ventricular contraction at baseline to RV pacing (OR: 2.42, 95% CI: 1.12-5.24, p = .02); and (3) a higher RV pacing burden (β: -0.05, 95% CI: -0.08--0.02, p < .01), respectively.
Worsening TR, MR, and LVEF after pacemaker implantation were not associated with the type of pacing device but loss of atrioventricular synchrony or dependency on RV pacing.
与经静脉起搏器(TPM)相比,目前对于导致无导线起搏器(LPM)植入后房室瓣反流和左心室(LV)收缩功能恶化的预测因素仍不清楚。
我们回顾性分析了 205 名新植入永久性起搏器的患者(119 例 LPM 和 86 例 TPM),并在植入前和植入后 8±5 个月进行了经胸超声心动图检查。我们评估了三尖瓣和二尖瓣反流(TR 和 MR)的恶化情况,定义为严重程度至少增加一级,并评估了 LV 射血分数(LVEF)的变化。
与 TPM 组相比,LPM 组发生 TR 恶化的比例更高(33% vs. 20%,p=0.04);然而,两组之间 MR 恶化(26% vs. 18%,p=0.18)和 LVEF 变化(-2±10% vs. -3±8%,p=0.40)没有显著差异。多变量分析发现,植入后 TR、MR 和 LVEF 恶化的独立预测因素为:(1)从基线窦性节律转变为房室不同步右心室(RV)起搏(优势比[OR]:5.68,95%置信区间[CI]:1.94-16.70,p<0.01);(2)从基线非起搏室性收缩转变为 RV 起搏(OR:2.42,95% CI:1.12-5.24,p=0.02);(3)RV 起搏负担更高(β:-0.05,95% CI:-0.08--0.02,p<0.01)。
起搏器植入后 TR、MR 和 LVEF 的恶化与起搏设备的类型无关,而是与房室同步丧失或对 RV 起搏的依赖有关。